Saved in:
| Main Authors: | Koedijk, Joost, Heidenreich, Olaf |
|---|---|
| Format: | Recurso digital |
| Language: | |
| Published: |
Zenodo
2027
|
| Online Access: | https://doi.org/10.5281/zenodo.14786669 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Isatuximab in combination with chemotherapy for pediatric patients with relapsed/refractory acute lymphoblastic leukemia or acute myeloid leukemia: The ISAKIDS study
by: André Baruchel, et al.
Published: (2025)
by: André Baruchel, et al.
Published: (2025)
Concurrent hyperdiploid acute myeloid leukemia and trisomy 12+ chronic lymphocytic leukemia
by: Tulasi Geevar, et al.
Published: (2024)
by: Tulasi Geevar, et al.
Published: (2024)
Venetoclax for pediatric patients with newly diagnosed acute myeloid leukemia
by: Amber Gibson, et al.
Published: (2024)
by: Amber Gibson, et al.
Published: (2024)
CD123‐targeting immunotherapeutic approaches in acute myeloid leukaemia
by: Alexandra Dreyzin, et al.
Published: (2025)
by: Alexandra Dreyzin, et al.
Published: (2025)
A tumor-immune model of chronic myeloid leukemia with optimal immunotherapeutic protocols
by: Zhang, Haifeng, et al.
Published: (2025)
by: Zhang, Haifeng, et al.
Published: (2025)
3-Bromopyruvate boosts the effect of chemotherapy in acute myeloid leukemia by a pro-oxidant mechanism.
by: Pereira-Vieira, Joana, et al.
Published: (2025)
by: Pereira-Vieira, Joana, et al.
Published: (2025)
Unlocking fresh perspectives: molecular breakthroughs in pediatric acute myeloid leukemia classification and prognosis
by: Yu Tao, et al.
Published: (2024)
by: Yu Tao, et al.
Published: (2024)
Bone marrow‐restricted aberrant myeloperoxidase expression in B‐acute lymphoblastic leukemia: A diagnostic dilemma and mimicry of mixed phenotype acute leukemia
by: Wei J. Wang, et al.
Published: (2024)
by: Wei J. Wang, et al.
Published: (2024)
Measurable residual disease by multicolor flow cytometry in acute myeloid leukemia: A comparison of peripheral blood and bone marrow
by: Jonas Schadt, et al.
Published: (2026)
by: Jonas Schadt, et al.
Published: (2026)
Successful venetoclax and azacitidine treatment in pediatric acute myeloid leukemia associated with familial platelet disorder
by: Rikako Tsukamoto, et al.
Published: (2025)
by: Rikako Tsukamoto, et al.
Published: (2025)
Long‐term follow‐up of VIALE‐A: Venetoclax and azacitidine in chemotherapy‐ineligible untreated acute myeloid leukemia
by: Keith W. Pratz, et al.
Published: (2024)
by: Keith W. Pratz, et al.
Published: (2024)
Glasdegib with intensive/nonintensive chemotherapy in Japanese patients with untreated acute myeloid leukemia or high‐risk myelodysplastic syndromes
by: Koji Izutsu, et al.
Published: (2024)
by: Koji Izutsu, et al.
Published: (2024)
Dismal outcome of refractory or relapsing patients with myelodysplasia‐related acute myeloid leukemia partially alleviated by intensive chemotherapy
by: Harmony Leroy, et al.
Published: (2024)
by: Harmony Leroy, et al.
Published: (2024)
Inflammatory signaling in the pathogenesis of acute myeloid leukemia
by: Artemis Margrith Baumann, et al.
Published: (2025)
by: Artemis Margrith Baumann, et al.
Published: (2025)
HTLV-1 infection in acute t- lymphocytic leukemia/lymphoma
by: Mohammad Barouqa
Published: (2021)
by: Mohammad Barouqa
Published: (2021)
Survival difference between secondary and de novo acute myeloid leukemia by age, antecedent cancer types, and chemotherapy receipt
by: Ephrem Sedeta, et al.
Published: (2024)
by: Ephrem Sedeta, et al.
Published: (2024)
Secondary acute myeloid leukemia and early infection are independent predictors of poor survival in acute myeloid leukemia treated with hypomethylating agents and venetoclax
by: Stefano Cordella, et al.
Published: (2024)
by: Stefano Cordella, et al.
Published: (2024)
A case of relapsed acute myeloid leukemia mimicking acute otomastoiditis
by: Ivan Negara, et al.
Published: (2024)
by: Ivan Negara, et al.
Published: (2024)
Leukemia cutis as the first manifestation of acute myeloid leukemia
by: Florian Winkler, et al.
Published: (2026)
by: Florian Winkler, et al.
Published: (2026)
ABO discrepancy with distinct mixed field reaction on forward typing in a pediatric acute myeloid leukemia patient
by: Yvonne Lam, et al.
Published: (2026)
by: Yvonne Lam, et al.
Published: (2026)
KIT ‐mutated pediatric core‐binding factor systemic mastocytosis‐acute myeloid leukemia treated with avapritinib and decitabine
by: Irtiza N. Sheikh, et al.
Published: (2024)
by: Irtiza N. Sheikh, et al.
Published: (2024)
Prognostic value of postinduction medullary myeloid recovery by flow cytometry in acute myeloid leukemia
by: Céline Row, et al.
Published: (2024)
by: Céline Row, et al.
Published: (2024)
Acute myocardial infarction in an untreated patient with acute myeloid leukemia
by: Doreen Kamoga, et al.
Published: (2024)
by: Doreen Kamoga, et al.
Published: (2024)
Venetoclax in the treatment of acute myeloid leukemia: Beyond VIALE‐A
by: Naseema Gangat, et al.
Published: (2024)
by: Naseema Gangat, et al.
Published: (2024)
Pursuing dynamics of minimal residual leukemic subclones in relapsed and refractory acute myeloid leukemia during conventional therapy
by: Dongchan Kim, et al.
Published: (2024)
by: Dongchan Kim, et al.
Published: (2024)
A rare presentation of BCR‐ABL1 and RUNX1‐MECOM rearrangement in a pediatric patient with acute myeloid leukemia
by: Ragdah M. Alamri, et al.
Published: (2024)
by: Ragdah M. Alamri, et al.
Published: (2024)
Extramedullary infiltration in pediatric acute myeloid leukemia: Results from the Therapeutically Applicable Research to Generate Effective Treatments (TARGET) initiative
by: Weiya Li, et al.
Published: (2024)
by: Weiya Li, et al.
Published: (2024)
Clonal dynamics of Richter transformation in chronic lymphocytic leukemia
by: Hanyin Wang, et al.
Published: (2024)
by: Hanyin Wang, et al.
Published: (2024)
Evaluating the role of Day 14 bone marrow biopsy and European LeukemiaNet risk classification in predicting overall and relapse‐free survival in acute myeloid leukemia
by: Metodi Balev, et al.
Published: (2024)
by: Metodi Balev, et al.
Published: (2024)
Mature plasmacytoid dendritic cell proliferation associated with acute myeloid leukemia
by: J. Maes, et al.
Published: (2024)
by: J. Maes, et al.
Published: (2024)
PIEZO1 is essential for the survival and proliferation of acute myeloid leukemia cells
by: Delphine Lebon, et al.
Published: (2024)
by: Delphine Lebon, et al.
Published: (2024)
Impact of secondary‐type mutations in acute myeloid leukemia with CEBPA mutation
by: Davidson Zhao, et al.
Published: (2024)
by: Davidson Zhao, et al.
Published: (2024)
Nanomaterials for acute myeloid leukemia therapy: Current progress and future perspectives
by: Jiarui Zhao, et al.
Published: (2025)
by: Jiarui Zhao, et al.
Published: (2025)
Contemporary outcomes of octa‐nonagenarians with newly diagnosed acute myeloid leukemia
by: Jayastu Senapati, et al.
Published: (2025)
by: Jayastu Senapati, et al.
Published: (2025)
Clinical, immunophenotypic, and genomic findings of acute myeloid leukemia with RAM immunophenotype: Comparison with other CD56‐positive acute leukemias
by: Hanan Hamdan, et al.
Published: (2024)
by: Hanan Hamdan, et al.
Published: (2024)
Bone marrow hematoidin crystals in a pediatric patient with chondroblastic osteosarcoma
by: Yun Zhang, et al.
Published: (2024)
by: Yun Zhang, et al.
Published: (2024)
Correction to “Extramedullary infiltration in pediatric acute myeloid leukemia: Results from the Therapeutically Applicable Research to Generate Effective Treatments (TARGET) initiative”
Published: (2024)
Published: (2024)
Age‐associated myeloid malignancies – the role of STAT3 and STAT5 in myelodysplastic syndrome and acute myeloid leukemia
by: Eirini Sofia Fasouli, et al.
Published: (2024)
by: Eirini Sofia Fasouli, et al.
Published: (2024)
Methylsulfonylmethane induces caspase‐dependent apoptosis in acute myeloid leukemia cell lines
by: Yalda Hekmatshoar, et al.
Published: (2024)
by: Yalda Hekmatshoar, et al.
Published: (2024)
FLT3‐ITD regulation of the endoplasmic reticulum functions in acute myeloid leukemia
by: María Turos‐Cabal, et al.
Published: (2024)
by: María Turos‐Cabal, et al.
Published: (2024)
Similar Items
-
Isatuximab in combination with chemotherapy for pediatric patients with relapsed/refractory acute lymphoblastic leukemia or acute myeloid leukemia: The ISAKIDS study
by: André Baruchel, et al.
Published: (2025) -
Concurrent hyperdiploid acute myeloid leukemia and trisomy 12+ chronic lymphocytic leukemia
by: Tulasi Geevar, et al.
Published: (2024) -
Venetoclax for pediatric patients with newly diagnosed acute myeloid leukemia
by: Amber Gibson, et al.
Published: (2024) -
CD123‐targeting immunotherapeutic approaches in acute myeloid leukaemia
by: Alexandra Dreyzin, et al.
Published: (2025) -
A tumor-immune model of chronic myeloid leukemia with optimal immunotherapeutic protocols
by: Zhang, Haifeng, et al.
Published: (2025)